Endometrial Neoplasms: all 1,347 studies
Page 9 of 14. Open to participants first (452), then studies with results posted, then the rest; newest registration first within each.
- The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer SurgeriesCompletedNCT04891146
- Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus IIStatus unknownNCT04890912Not applicable
- An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer PatientsStatus unknownNCT04885413Phase 2
- Study of AK112 in the Treatment of Advanced Gynecological TumorsCompletedNCT04870177Phase 2
- HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal BleedingStatus unknownNCT04867109
- Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruSStatus unknownNCT04866394Not applicable
- Analysis of miRNA Expression in Endometrial CancerStatus unknownNCT04845425
- A Study of TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic TumorsStatus unknownNCT04836663Phase 2
- Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor HistologyCompletedNCT04830332Not applicable
- 4FMFES-PET Imaging of Endometrial and Ovarian CancersCompletedNCT04823065Phase 1/2
- Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive SystemCompletedNCT04817501
- Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial CancerStatus unknownNCT04792749Phase 3
- Endometrial Cancer International DatabaseStatus unknownNCT04787159
- Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid TumorsActive, not recruitingNCT04780217Phase 1/2
- Improving Care After Inherited Cancer TestingActive, not recruitingNCT04763915Not applicable
- Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyActive, not recruitingNCT04713618
- TH1902 in Patients With Advanced Solid TumorsActive, not recruitingNCT04706962Phase 1
- Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial CancerCompletedNCT04705649Not applicable
- Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialActive, not recruitingNCT04704661Phase 1
- Study of Pelvic Hypofractionated Radiotherapy in Endometrial CancerSuspendedNCT04683653Phase 1/2
- Expanded Access Use of DKN-01 for the Treatment of Advanced Solid TumorsNo longer availableNCT04681248
- Infertility Survey Among Reproductive Age Women With Gynecological and Breast CancerActive, not recruitingNCT04678414
- Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerCompletedNCT04670445Not applicable
- A Study of SGN-STNV in Advanced Solid TumorsTerminatedNCT04665921Phase 1
- Tracers for Endometrial Cancer Sentinel Node LabelingStatus unknownNCT04665544Not applicable
- CAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsActive, not recruitingNCT04660929Phase 1
- GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or PembrolizumabActive, not recruitingNCT04652076Phase 1/2
- Cell-free DNA Methylation for Endometrial CancerStatus unknownNCT04651738Not applicable
- Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive, not recruitingNCT04644068Phase 1/2
- Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)Active, not recruitingNCT04634877Phase 3
- Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer SurvivorsActive, not recruitingNCT04634617
- Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN CancersCompletedNCT04626895Not applicable
- Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Complete Blood Count During and After Pelvic IrradiationCompletedNCT04626466
- Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersWithdrawnNCT04611139Phase 1
- Relationship of Endometrial Cancer and Serum Soluble L1CAM LevelCompletedNCT04603599
- Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.TerminatedNCT04586335Phase 1
- A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial CancerStatus unknownNCT04577950Not applicable
- Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial CancerActive, not recruitingNCT04576104Phase 2
- A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial CancerCompletedNCT04574284Phase 2
- COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.CompletedNCT04570839Phase 1/2
- Choosing Ovarian Preservation or Removal Before Surgery for Endometrial CancerActive, not recruitingNCT04569773
- Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003)CompletedNCT04560491
- Behavioral Weight Loss Program for Cancer Survivors in MarylandCompletedNCT04534309Not applicable
- Tumor Grade Determines PD-1/PDL-1 ExpressionStatus unknownNCT04528940
- Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair MutationStatus unknownNCT04516083
- To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial CancerStatus unknownNCT04514289
- A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ TumorsActive, not recruitingNCT04503278Phase 1
- Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial CarcinomaCompletedNCT04491643Phase 2
- Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 MutationStatus unknownNCT04489706Not applicable
- TTX-080 HLA-G Antagonist in Subjects With Advanced CancersActive, not recruitingNCT04485013Phase 1
- Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death RatesCompletedNCT04474184Phase 1
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnNCT04464967Phase 1/2
- Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.CompletedNCT04463771Phase 2
- Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial CancerCompletedNCT04458402Not applicable
- Study of PF-07265807 in Participants With Metastatic Solid Tumors.TerminatedNCT04458259Phase 1
- Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.CompletedNCT04456972Not applicable
- Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch SyndromeCompletedNCT04452266
- Durvalumab and Lenvatinib in Participants With Advanced and Recurrent Endometrial CarcinomaStatus unknownNCT04444193Not applicable
- Immunoassay and Regulation of Traditional Chinese Medicine on Cancer PatientsStatus unknownNCT04438564Not applicable
- Predictors of Recurrence for High Risk Endometrial Cancer PatientsCompletedNCT04412902
- Abemaciclib and Letrozole to Treat Endometrial CancerActive, not recruitingNCT04393285Phase 2
- De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial CancerCompletedNCT04386993Not applicable
- Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid TumorsCompletedNCT04344795Phase 1
- Effectiveness of Care in Certified Cancer Centres in GermanyCompletedNCT04334239
- A Novel Tapered Applicator for Vaginal Vault BrachytherapyCompletedNCT04318340Not applicable
- Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial CancerCompletedNCT04302714Not applicable
- Gyn Onc Prehab StudyCompletedNCT04298827Not applicable
- Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal FunctionStatus unknownNCT04295109Not applicable
- Quality of Life After Robotic Surgery for Endometrial CancerCompletedNCT04281043
- A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsTerminatedNCT04278144Phase 1/2
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsTerminatedNCT04272034Phase 1
- Onco-primary Care Networking to Support TEAM-based CareActive, not recruitingNCT04258813Not applicable
- Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesCompletedNCT04257045
- Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival AnalysisStatus unknownNCT04251676
- A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial CarcinomaActive, not recruitingNCT04251416Phase 2
- Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical CancerCompletedNCT04246580
- Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial CancerCompletedNCT04240730
- Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to PaclitaxelCompletedNCT04237090Phase 3
- The Application of Real-Time Near-infrared Imaging in Gynecological SurgeryStatus unknownNCT04224467Not applicable
- Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World StudyStatus unknownNCT04214964
- Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic ModelCompletedNCT04212910
- Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer PatientsCompletedNCT04212377Phase 2
- Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.CompletedNCT04205864Not applicable
- Pembrolizumab With Axitinib in Recurrent Endometrial CancerWithdrawnNCT04197219Phase 2
- A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial CancerActive, not recruitingNCT04188548Phase 1
- A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior TreatmentTerminatedNCT04178460Phase 1
- Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium CancerCompletedNCT04175067
- A Study of Various Treatments in Serous or p53 Abnormal Endometrial CancerTerminatedNCT04159155Phase 2/3
- Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial CancerStatus unknownNCT04157491Phase 1/2
- Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)Active, not recruitingNCT04152499Phase 1/2
- The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology StudyCompletedNCT04122235Not applicable
- Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial CarcinomaCompletedNCT04120649
- Clinical Application of Laparo-endoscopic Single-site Surgery and Natural Orifice Transluminal Endoscopic in GynecologyStatus unknownNCT04096872
- Trial of Maintenance With Niraparib- Uterine Serous CarcinomaCompletedNCT04080284Phase 2
- A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid TumorsStatus unknownNCT04073680Phase 1/2
- Effects of Centering Pre-operative Counseling on Patient Reported AnxietyCompletedNCT04068675Not applicable
- ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no LossActive, not recruitingNCT04065269Phase 2
- Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial CancerStatus unknownNCT04046185Early Phase 1
- ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)Active, not recruitingNCT04044859Phase 1
- Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.CompletedNCT04021459Not applicable